Targeted Cancer Therapies
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
Treatment Resistent Cancers
Inhibitors of Viral Protein Synthesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 23, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
1I. Internen Abteilung, Krankenhauses der Elisabethinen, Linz.
Interferon-alpha (IFN-alpha) therapy shows significant remission rates for chronic myelogenic leukemia (CML) patients. High doses and combination therapies may improve outcomes, despite common flu-like side effects.
Area of Science: